Tellic

About Tellic

Tellic operates at the intersection of life sciences, data science, and DevOps, pioneering a new category of enterprise-scale biomedical language processing and knowledge discovery. The company leverages advanced machine learning techniques to provide pharmaceutical companies with unprecedented insights, enabling them to make breakthrough drug research and development (R&D) decisions. Tellic's solutions help accelerate the development of life-enhancing drugs, ensuring they reach patients who need them faster.

Tellic serves pharmaceutical companies and biomedical researchers, operating within the pharmaceutical and biotech markets. The business model revolves around providing a subscription-based software platform that integrates large language models, natural language processing (NLP), and knowledge graphs to form a single source of truth for biomedical concepts. This platform significantly increases the efficiency of researchers and analysts by streamlining the search process across multiple data sources, thereby reducing wasted time and missed opportunities.

Revenue is generated through subscription fees for access to the platform, as well as potential consulting services for customized data solutions. Tellic's commitment to innovation, data-driven decision-making, and excellence in customer service positions it as a leader in the biomedical data science field.